Forte Biosciences Inc. (FBRX)
NASDAQ:FBRX

Forte Biosciences (FBRX) Financial Statements

251 Followers

Forte Biosciences Financial Overview

Forte Biosciences's market cap is currently ―. The company's EPS TTM is $-1.008; its P/E ratio is -0.56; Forte Biosciences is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.42M$ -7.00M$ -9.96M$ -8.90M$ -6.75M
EBITDA$ -7.41M$ -6.99M$ -9.93M$ -8.92M$ -6.75M
Net Income Common Stockholders$ -7.42M$ -5.87M$ -9.96M$ -8.90M$ -6.75M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 30.40M$ 37.10M$ 46.20M$ 30.39M$ 35.90M
Total Assets$ 32.02M$ 38.98M$ 47.88M$ 31.15M$ 36.71M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -30.40M$ -37.10M$ -46.20M$ -30.39M$ -35.90M
Total Liabilities$ 3.33M$ 3.67M$ 7.47M$ 6.30M$ 3.76M
Stockholders Equity$ 28.68M$ 35.31M$ 40.41M$ 24.88M$ 32.95M
Cash Flow-
Free Cash Flow$ -6.71M$ -9.02M$ -9.07M$ -5.47M$ -5.20M
Operating Cash Flow$ -6.70M$ -9.00M$ -9.00M$ -5.47M$ -5.20M
Investing Cash Flow$ -6.00K$ -16.00K$ 10.03M$ -9.96M-
Financing Cash Flow$ -8.00K$ -75.00K$ 24.78M$ -24.00K$ 6.00K
Currency in USD

Forte Biosciences Earnings and Revenue History

Forte Biosciences Debt to Assets

Forte Biosciences Cash Flow

Forte Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis